2015 Q2 Form 10-Q Financial Statement

#000156459015006825 Filed on August 10, 2015

View on sec.gov

Income Statement

Concept 2015 Q2 2014 Q2
Revenue $306.0K $99.00K
YoY Change 209.09% -6.6%
Cost Of Revenue $0.00
YoY Change
Gross Profit $306.0K
YoY Change
Gross Profit Margin 100.0%
Selling, General & Admin $4.622M $3.695M
YoY Change 25.09% 56.7%
% of Gross Profit 1510.46%
Research & Development $4.142M $2.814M
YoY Change 47.19% 89.88%
% of Gross Profit 1353.59%
Depreciation & Amortization $135.0K $96.00K
YoY Change 40.63% 3.23%
% of Gross Profit 44.12%
Operating Expenses $8.764M $6.509M
YoY Change 34.64% 69.51%
Operating Profit -$8.458M -$6.410M
YoY Change 31.95% 71.67%
Interest Expense $3.000K $0.00
YoY Change -100.0%
% of Operating Profit
Other Income/Expense, Net -$33.00K -$23.00K
YoY Change 43.48% -37.84%
Pretax Income -$8.490M -$6.430M
YoY Change 32.04% 70.56%
Income Tax $3.000K $0.00
% Of Pretax Income
Net Earnings -$8.491M -$6.433M
YoY Change 31.99% 70.59%
Net Earnings / Revenue -2774.84% -6497.98%
Basic Earnings Per Share
Diluted Earnings Per Share -$1.887M -$1.645M
COMMON SHARES
Basic Shares Outstanding 78.28M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2015 Q2 2014 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $86.00M $44.90M
YoY Change 91.54% 249.42%
Cash & Equivalents $86.00M $44.90M
Short-Term Investments
Other Short-Term Assets $800.0K $710.0K
YoY Change 12.68% 115.15%
Inventory $70.00K $71.00K
Prepaid Expenses
Receivables $130.0K $60.00K
Other Receivables $0.00 $0.00
Total Short-Term Assets $87.00M $45.74M
YoY Change 90.21% 244.95%
LONG-TERM ASSETS
Property, Plant & Equipment $3.380M $1.001M
YoY Change 237.66% -9.82%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $190.0K $88.00K
YoY Change 115.91% -32.31%
Total Long-Term Assets $3.560M $1.168M
YoY Change 204.79% -6.56%
TOTAL ASSETS
Total Short-Term Assets $87.00M $45.74M
Total Long-Term Assets $3.560M $1.168M
Total Assets $90.56M $46.91M
YoY Change 93.06% 223.28%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.030M $839.0K
YoY Change 22.77% 126.76%
Accrued Expenses $2.730M $1.739M
YoY Change 56.99% 52.54%
Deferred Revenue
YoY Change
Short-Term Debt $30.00K $0.00
YoY Change
Long-Term Debt Due $0.00 $10.00K
YoY Change -100.0% 0.0%
Total Short-Term Liabilities $5.230M $3.085M
YoY Change 69.53% -59.3%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change -100.0%
Other Long-Term Liabilities $20.00K $0.00
YoY Change -100.0%
Total Long-Term Liabilities $20.00K $0.00
YoY Change -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $5.230M $3.085M
Total Long-Term Liabilities $20.00K $0.00
Total Liabilities $5.240M $3.090M
YoY Change 69.58% -59.34%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock $78.00K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $85.32M $43.82M
YoY Change
Total Liabilities & Shareholders Equity $90.56M $46.91M
YoY Change 93.06% 223.28%

Cashflow Statement

Concept 2015 Q2 2014 Q2
OPERATING ACTIVITIES
Net Income -$8.491M -$6.433M
YoY Change 31.99% 70.59%
Depreciation, Depletion And Amortization $135.0K $96.00K
YoY Change 40.63% 3.23%
Cash From Operating Activities -$6.300M $3.400M
YoY Change -285.29% -227.82%
INVESTING ACTIVITIES
Capital Expenditures $1.135M $238.0K
YoY Change 376.89% 46.01%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change -100.0%
Cash From Investing Activities -$1.140M -$240.0K
YoY Change 375.0% 118.18%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $46.10M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 43.29M 330.0K
YoY Change 13018.18%
NET CHANGE
Cash From Operating Activities -6.300M 3.400M
Cash From Investing Activities -1.140M -240.0K
Cash From Financing Activities 43.29M 330.0K
Net Change In Cash 35.85M 3.400M
YoY Change 954.41% -222.74%
FREE CASH FLOW
Cash From Operating Activities -$6.300M $3.400M
Capital Expenditures $1.135M $238.0K
Free Cash Flow -$7.435M $3.162M
YoY Change -335.14% -212.01%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2014Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-6410000
CY2015Q2 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
-38000
CY2014Q2 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
-30000
CY2015Q2 us-gaap Interest Expense
InterestExpense
3000
CY2014Q2 us-gaap Interest Expense
InterestExpense
0
CY2015Q2 us-gaap Net Income Loss
NetIncomeLoss
-8491000
CY2015Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.10
CY2015Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
82993966
CY2015Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
135000
CY2014Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
96000
CY2015Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
38000
CY2014Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
30000
CY2015Q2 us-gaap Share Based Compensation
ShareBasedCompensation
1780000
CY2014Q2 us-gaap Share Based Compensation
ShareBasedCompensation
1537000
CY2015Q2 us-gaap Adjustment Of Warrants Granted For Services
AdjustmentOfWarrantsGrantedForServices
-95000
CY2014Q2 us-gaap Adjustment Of Warrants Granted For Services
AdjustmentOfWarrantsGrantedForServices
141000
CY2015Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
132000
CY2014Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
60000
CY2015Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3000
CY2014Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
8000
CY2015Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-256000
CY2014Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-117000
CY2015Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-357000
CY2014Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
513000
CY2015Q2 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-611000
CY2014Q2 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
460000
CY2015Q2 onvo Increase Decrease In Deferred Rent
IncreaseDecreaseInDeferredRent
-8000
CY2014Q2 onvo Increase Decrease In Deferred Rent
IncreaseDecreaseInDeferredRent
112000
CY2015Q2 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
1193000
CY2014Q2 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
130000
CY2015Q2 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-6295000
CY2014Q2 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-3365000
CY2015Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1135000
CY2014Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
238000
CY2015Q2 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-1135000
CY2014Q2 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-238000
CY2015Q2 onvo Proceeds From Issuance Of Common Stock And Warrants
ProceedsFromIssuanceOfCommonStockAndWarrants
43214000
CY2014Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3695000
CY2014Q2 us-gaap Net Income Loss
NetIncomeLoss
-6433000
CY2015Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4622000
CY2015Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-8458000
CY2015Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-33000
CY2014Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.08
CY2014Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
78241373
CY2015Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000
CY2015Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2015Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
8000
CY2014Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
7000
CY2014Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-23000
CY2014Q2 onvo Proceeds From Issuance Of Common Stock And Warrants
ProceedsFromIssuanceOfCommonStockAndWarrants
224000
CY2015Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
77000
CY2014Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
111000
CY2015Q2 us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
3000
CY2014Q2 us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
2000
CY2015Q2 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
43288000
CY2014Q2 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
333000
CY2015Q2 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
35858000
CY2014Q2 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-3270000
CY2014Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
48167000
CY2014Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
44897000
CY2015Q2 us-gaap Interest Paid
InterestPaid
0
CY2014Q2 us-gaap Interest Paid
InterestPaid
0
CY2015Q2 us-gaap Income Taxes Paid
IncomeTaxesPaid
3000
CY2014Q2 us-gaap Income Taxes Paid
IncomeTaxesPaid
0
CY2015Q2 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
138000
CY2014Q2 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
55000
CY2015Q2 onvo Leasehold Improvements Funded By Lease Incentive
LeaseholdImprovementsFundedByLeaseIncentive
337000
CY2015Q2 us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Use of estimates </p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of the financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect certain reported amounts and disclosures. Accordingly, actual results could differ from those estimates. Significant estimates used in preparing the condensed consolidated financial statements include those assumed in computing the valuation of warrants, revenue recognized under the proportional performance model, the valuation of stock-based compensation expense, and the valuation allowance on deferred tax assets. </p></div>
CY2015Q2 us-gaap Revenue Recognition Multiple Element Arrangements
RevenueRecognitionMultipleElementArrangements
<div> <p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Revenue arrangements with multiple deliverables </p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company periodically enters into revenue arrangements that contain multiple deliverables. Judgment is required to properly identify the accounting units of the multiple deliverable transactions and to determine the manner in which revenue should be allocated among the accounting units. Moreover, judgment is used in interpreting the commercial terms and determining when all criteria of revenue recognition have been met for each deliverable in order for revenue recognition to occur in the appropriate accounting period. For multiple deliverable agreements, consideration is allocated at the inception of the agreement to all deliverables based on their relative selling price. The relative selling price for each deliverable is determined using vendor-specific objective evidence (&#8220;VSOE&#8221;) of selling price or third-party evidence of selling price if VSOE does not exist. If neither VSOE nor third-party evidence of selling price exists, the Company uses its best estimate of the selling price for the deliverable. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">While changes in the allocation of the arrangement consideration between the units of accounting will not affect the amount of total revenue recognized for a particular sales arrangement, any material changes in these allocations could impact the timing of revenue recognition, which could affect the Company&#8217;s results of operations. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company expects to periodically receive license fees for non-exclusive research licensing associated with funded research projects. License fees under these arrangements are recognized over the term of the contract or development period as it has been determined that such licenses do not have stand-alone value. </p></div>
CY2015Q2 us-gaap Revenue Recognition Sales Of Goods
RevenueRecognitionSalesOfGoods
<div> <p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Product revenue </p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company recognizes product revenue at the time of shipment to the customer, provided all other revenue recognition criteria have been met. To date, the Company has not recognized significant revenue from commercial product sales.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As our commercial sales increase, we expect to establish a reserve for estimated product returns that will be recorded as a reduction to revenue. That reserve will be maintained to account for future return of products sold in the current period. The reserve will be reviewed quarterly and will be estimated based on an analysis of our historical experience related to product returns.</p></div>
CY2015Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
10838750
CY2015Q2 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
46100000
CY2015Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
32000
CY2015Q1 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
31000
CY2015Q2 us-gaap Property Plant And Equipment Estimated Useful Lives
PropertyPlantAndEquipmentEstimatedUsefulLives
The estimated useful lives of the fixed assets range between three and seven years.
CY2015Q2 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2015Q2 us-gaap Dilutive Securities
DilutiveSecurities
0
CY2014Q2 us-gaap Dilutive Securities
DilutiveSecurities
0
CY2015Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.22
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
4.94
CY2015Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
15200000
CY2013Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
75000
CY2013Q4 onvo Class Of Warrant Or Right Life
ClassOfWarrantOrRightLife
P5Y
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.9690
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0060
CY2015Q2 onvo Warrant Or Right Expense Or Revenue Recognized
WarrantOrRightExpenseOrRevenueRecognized
101000
CY2013Q4 onvo Warrant Earning Period Through Issuance Of Common Stock
WarrantEarningPeriodThroughIssuanceOfCommonStock
P12M
CY2015Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
10200000
CY2014Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7800000
CY2011 onvo Class Of Warrant Or Right Life
ClassOfWarrantOrRightLife
P5Y
CY2012 onvo Class Of Warrant Or Right Life
ClassOfWarrantOrRightLife
P5Y
CY2015Q2 onvo Number Of Warrant Exercised During Period Recorded As Derivative Liability
NumberOfWarrantExercisedDuringPeriodRecordedAsDerivativeLiability
38234
CY2014Q2 onvo Number Of Warrant Exercised During Period Recorded As Derivative Liability
NumberOfWarrantExercisedDuringPeriodRecordedAsDerivativeLiability
8647
CY2013Q3 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
4.50
CY2013Q3 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
43400000
CY2013Q3 us-gaap Expense Related To Distribution Or Servicing And Underwriting Fees
ExpenseRelatedToDistributionOrServicingAndUnderwritingFees
3200000
CY2015Q2 onvo Stockholders Equity During Period Issuance Of Common Stock From Warrant Exercises
StockholdersEquityDuringPeriodIssuanceOfCommonStockFromWarrantExercises
30186
CY2014Q2 onvo Stockholders Equity During Period Issuance Of Common Stock From Warrant Exercises
StockholdersEquityDuringPeriodIssuanceOfCommonStockFromWarrantExercises
110600
CY2015Q2 us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
38234
CY2014Q2 us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
111647
CY2015Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
25503
CY2014Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
60522
CY2015Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
25503
CY2014Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
60522
CY2015Q2 onvo Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Upon Return Of Common Shares
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodUponReturnOfCommonShares
2259
CY2014Q3 onvo Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Upon Return Of Common Shares
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodUponReturnOfCommonShares
2301
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
7113548
CY2015Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1762641
CY2015Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
24003
CY2015Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
61484
CY2015Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
5493770
CY2015Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
4641630
CY2015Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P7Y6M7D
CY2015Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y6M7D
CY2015Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00
CY2015Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.7425
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.7802
CY2015Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0165
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0156
CY2015Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
CY2014Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
onvo Common Stock Warrants Issued
CommonStockWarrantsIssued
50000
CY2014Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
145000
onvo Leasehold Improvements Funded By Lease Incentive
LeaseholdImprovementsFundedByLeaseIncentive
481000
CY2015Q2 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
277000
CY2014Q4 onvo Class Of Warrant Or Right Life
ClassOfWarrantOrRightLife
P5Y
CY2014Q4 onvo Warrant Earning Period Through Issuance Of Common Stock
WarrantEarningPeriodThroughIssuanceOfCommonStock
P17M
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.7678
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0137
CY2015Q2 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
11116595
CY2014Q2 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
235000
CY2015Q2 onvo Operating Leases Monthly Base Rent Expense
OperatingLeasesMonthlyBaseRentExpense
38800
CY2015Q2 us-gaap Operating Leases Of Lessee Contingent Rentals Basis Spread On Variable Rate
OperatingLeasesOfLesseeContingentRentalsBasisSpreadOnVariableRate
0.03
CY2015Q2 onvo Lease Term With Option To Extend
LeaseTermWithOptionToExtend
P48M
CY2013Q4 onvo Increased Office Space Headquarters
IncreasedOfficeSpaceHeadquarters
15268
CY2013Q4 onvo Additional Leased Office Space
AdditionalLeasedOfficeSpace
15539
CY2013Q4 onvo Office Space Area Under Lease Agreement
OfficeSpaceAreaUnderLeaseAgreement
30807
CY2013Q4 onvo Operating Leases Monthly Base Rent Expense
OperatingLeasesMonthlyBaseRentExpense
38800
CY2013Q4 us-gaap Lease Expiration Date1
LeaseExpirationDate1
2016-08-01
CY2013Q4 onvo Operating Leases Monthly Rent Expense
OperatingLeasesMonthlyRentExpense
38934
CY2013Q4 us-gaap Operating Leases Of Lessee Contingent Rentals Basis Spread On Variable Rate
OperatingLeasesOfLesseeContingentRentalsBasisSpreadOnVariableRate
0.03
CY2013Q4 onvo Additional Office Space
AdditionalOfficeSpace
14500
CY2015Q2 onvo Lease Amendment Effective Date
LeaseAmendmentEffectiveDate
2014-09-01
CY2015Q1 onvo Increased Office Space Headquarters
IncreasedOfficeSpaceHeadquarters
335
CY2015Q1 onvo Increase Of Net Adjustment Leased Space
IncreaseOfNetAdjustmentLeasedSpace
88
CY2015Q1 onvo Additional Leased Office Space
AdditionalLeasedOfficeSpace
5803
CY2015Q1 us-gaap Lessee Leasing Arrangements Operating Leases Term Of Contract
LesseeLeasingArrangementsOperatingLeasesTermOfContract
P36M
CY2015Q1 onvo Lease Rental Period Start Date
LeaseRentalPeriodStartDate
2015-02-01
CY2015Q1 onvo Lease Rental Period End Date
LeaseRentalPeriodEndDate
2018-01-31
CY2015Q1 onvo Operating Leases Monthly Base Rent Expense
OperatingLeasesMonthlyBaseRentExpense
12000
CY2015Q1 us-gaap Operating Leases Of Lessee Contingent Rentals Basis Spread On Variable Rate
OperatingLeasesOfLesseeContingentRentalsBasisSpreadOnVariableRate
0.030
CY2015Q2 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
861000
CY2015Q2 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
1157000
CY2015Q2 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
1145000
CY2015Q2 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
1041000
CY2015Q2 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
1072000
CY2015Q2 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
1571000
CY2015Q2 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
6847000

Files In Submission

Name View Source Status
0001564590-15-006825-index-headers.html Edgar Link pending
0001564590-15-006825-index.html Edgar Link pending
0001564590-15-006825.txt Edgar Link pending
0001564590-15-006825-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
onvo-10q_20150630.htm Edgar Link pending
onvo-20150630.xml Edgar Link completed
onvo-20150630.xsd Edgar Link pending
onvo-20150630_cal.xml Edgar Link unprocessable
onvo-20150630_def.xml Edgar Link unprocessable
onvo-20150630_lab.xml Edgar Link unprocessable
onvo-20150630_pre.xml Edgar Link unprocessable
onvo-ex311_8.htm Edgar Link pending
onvo-ex312_6.htm Edgar Link pending
onvo-ex321_7.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending